SK Biopharmaceuticals. (326030.KQ) Q2 2025 Earnings

May 9Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
85
829
1,573
2,318

Details

Expected EPS
252
Actual EPS
236
Surprise EPS
-16
Surprise Percent
-6.46%

Description

⁨SK Biopharmaceuticals.⁩ (⁦326030.KQ⁩) has reported earnings of ⁦236⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts